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Abstract
Glutamine plays a central role in the metabolism of critical biological molecules such as amino acids, proteins,
neurotransmitters, and glutathione. Since glutamine metabolism is regulated through multiple enzymes and transporters,
the cellular glutamine concentration is expected to be temporally dynamic. Moreover, differentiation in glutamine
metabolism between cell types in the same tissue (e.g. neuronal and glial cells) is often crucial for the proper function of the
tissue as a whole, yet assessing cell-type specific activities of transporters and enzymes in such heterogenic tissue by
physical fractionation is extremely challenging. Therefore, a method of reporting glutamine dynamics at the cellular level is
highly desirable. Genetically encoded sensors can be targeted to a specific cell type, hence addressing this knowledge gap.
Here we report the development of Fo ¨ster Resonance Energy Transfer (FRET) glutamine sensors based on improved cyan
and yellow fluorescent proteins, monomeric Teal Fluorescent Protein (mTFP)1 and venus. These sensors were found to be
specific to glutamine, and stable to pH-changes within a physiological range. Using cos7 cells expressing the human
glutamine transporter ASCT2 as a model, we demonstrate that the properties of the glutamine transporter can easily be
analyzed with these sensors. The range of glutamine concentration change in a given cell can also be estimated using
sensors with different affinities. Moreover, the mTFP1-venus FRET pair can be duplexed with another FRET pair, mAmetrine
and tdTomato, opening up the possibility for real-time imaging of another molecule. These novel glutamine sensors will be
useful tools to analyze specificities of glutamine metabolism at the single-cell level.
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Introduction
Glutamine is essential as the precursor for other amino acids
such as glutamate, histidine, proline and arginine, as well as many
other important biological molecules such as proteins, nucleic
acids [1], amino sugars [2] and glutathione [3,4]. It is also
a preferred fuel for rapidly dividing cells such as enterocytes,
fibroblasts and lymphocytes [5,6], and it serves as an important
precursor for neurotransmitters glutamate and GABA [7,8,9,10].
Because glutamine occupies a central position in primary and
secondary metabolism, glutamine availability has a large impact
on anabolism of downstream molecules. For example, recent
studies using an epileptic model brain suggested that the
availability of glutamine influences the amount of synaptically
released glutamate [11,12]. Moreover, in addition to its roles as an
anabolic precursor, evidence suggests that glutamine has regula-
tory roles over many cellular functions such as cell swelling-
induced signaling [13] and apoptosis [14]. Recent studies suggest
that glutamine induces a drastic change in gene expression (,1%
of analyzed genes) in pancreatic b-cell lines [15], as well as when
administered as a dietary supplement. Therefore, the cellular
glutamine level has a large impact on cell physiology, through the
regulation of both glutamine-derived molecules, and glutamine-
controlled cellular functions.
The control of cellular glutamine levels is a very complex
process. The activity of glutamine synthetase, the enzyme that
synthesizes glutamine from glutamate and ammonium, is regulat-
ed by a wide range of mechanisms including allosteric regulation
by substrates [16], assembly of subunits [17] and transcriptional
regulation by glucocorticoids and b-catenin [18,19,20]. Glutamin-
ase and glutamine transporters such as system N and ASCT
transporters are subject to both transcriptional and post-transcrip-
tional regulation [21,22,23]. In addition to the environmental
regulation exerted by the above mechanisms, the regulation of
glutamine metabolism is highly cell-type specific. In the mamma-
lian liver, two separate cell types are involved in a sequential
glutamine degradation and synthesis; the cells in the periportal
region generate ammonium from glutamine to provide ammonia
necessary for the production of urea, whereas in the perivenous
hepatocyte, glutamine is synthesized by glutamine synthetase to
scavenge excess ammonia that escaped the urea cycle [24,25,26].
Cellular specialization of glutamine metabolism is also found in
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38591neuronal tissues of animals. Glutamate released from the neuronal
cells is taken up by the surrounding glial cells and converted into
glutamine, which is not a transmitter molecule. The synthesized
glutamine is then shuttled back to the neuron where it is degraded
into glutamate to replenish the neurotransmitter pool. This so-
called glutamine-glutamate shuttle is considered to be important in
sustaining neuronal activities [7,8].
Because of the multiple levels of regulation and the heterologous
functions of different cell types, it is not surprising that the
concentration of glutamine varies greatly between cell types. For
example, glutamine is found in high concenrations in oligoden-
drocytes and astrocytes (22 mM), but at much lower concentra-
tions in glutamatergic terminals (4–11 mM) [27]. Likewise, in
hepatocytes glutamine is reported to be 20 mM, but the
stimulation of glutaminase or glutamine transaminase leads to
a decrease of glutamine concentration by 80% and 30%,
respectively [28]. In cancerous cells with activated glutamine
catabolism, the glutamine concentration was found to be much
lower than in cells with a lower rate of glutamine catabolism [29].
Genetically encoded sensors targeted to a single cell type or to
a subcellular compartment would provide an alternative approach
to analyze the dynamic regulation of metabolites in a single cell. A
set of FRET sensors for glutamine has previously been reported,
and was successfully used to monitor glutamine concentrations in
plant cells [30]. However, these sensors were limited in the range
of glutamine concentration that can be detected due to relatively
low affinity (6.8 and 18.8 mM). Also, enhanced cyan- and yellow-
fluorescent protein (ECFP and EYFP) were used as the FRET
pair, which is difficult to multiplex with other FRET pairs. Here
we report an array of improved FRET-based glutamine sensors
based on the E.coli glutamine binding protein, glnH. The sensors
consist of a recently reported FRET pair, monomeric Teal
Fluorescent Protein (mTFP)1 and venus. Both mTFP1 and venus
have improved quantum efficiency and pH stability compared to
the more commonly used FRET donor, ECFP and EYFP [31,32].
Moreover, the mTFP1-venus FRET pair can be duplexed with
another pair, mAmetrine-tdTomato [33]. We demonstrate that
the glutamine uptake and efflux can be monitored using these
glutamine sensors, making it an attractive tool to analyze the
properties of transporters expressed in a given cell. The properties
of transporters such as substrate specificity and dependency on
sodium gradient could easily be monitored. In addition, using
sensors with different affinities, we show that a wide range of
cytosolic glutamine concentrations can be monitored.
Results and Discussion
FRET Glutamine Sensor Using mTFP1-Venus FRET Pair
Previously developed glutamine sensors using the CFP/YFP
FRET pair are not compatible with other protein-based FRET
pairs because of substantial excitation/emission spectra overlap
[34]. In addition, the excitation maxima of CFP (428 nm) is not
ideal for imaging using confocal microscopy. Recently, Ai et al.
reported an improved cyan fluorescent protein (FP) from coral,
mTFP1, which has higher quantum efficiency and improved pH
stability [31]. Moreover, two protein-based FRET pairs, mTFP1/
Citrine (enhanced Yellow FP) and mAmetrine/tdTomato are
spectrally orthogonal and therefore can be used for dual-FRET
measurement [35]. We examined whether glnH (accession:
NP_415332), the high affinity glutamine binding protein from
E.coli, could be converted into a FRET sensor using mTFP1 and
an improved yellow FP, venus [32].
The sites of attachment for the donor and acceptor molecules
influence FRET efficiency, because they influence both the
distance between fluorophores and dipole-dipole orientation.
The crystal structure of glnH in both the open and closed form
has been published previously [36,37]. One of the lobes of glnH
contains a large hairpin-like structure close to its N terminus,
which allows insertion of the FPs (Fig. 1A, the permissive position
is indicated in magenta). It has previously been demonstrated that
insertion of ECFP in the corresponding location in the glutamate
binding protein ybeJ, which is structurally related to glnH, does
not interfere with the binding of glutamate to the chimera protein
[38]. Therefore, we systematically tested combinations of these
three possible insertion sites for the donor and acceptor proteins
(Fig. 1B). For venus, it is known that terminal regions (an N-
terminal helix and a C-terminal coil) are not required for the
fluorescence [38]. Therefore, in addition to full-length venus,
a series of clones that had part of the N- and C- terminal amino
acids removed were used in order to find the optimal linker length.
Among the constructs examined, we found one functional
mTFP1/venus based glutamine sensor, named FLIPQ-
TV(mTFP/Venus) 1.0 (Fig. 1B). In this configuration, mTFP1
and venus are located in the same lobe, hence the conformational
change in the glnH domain is unlikely to induce a significant
change in the distance between the two FPs. However, the binding
of glutamine causes a shift of the second lobe, opening up a larger
space in the vicinity of C-terminus where the venus molecule is
fused (Fig.S1). Such a change is likely to increase the accessible
space that the venus protein can occupy due to the decrease in
sterical constraint, hence affecting the FRET efficiency between
the two FPs. In fact, a number of type II periplasmic binding
proteins, in which N- and C- termini are located in the same lobe,
can be converted into a functional FRET sensors when the two
FPs are fused on the N- and C- termini [38,39,40].
The emission from the donor and acceptor changed reciprocally
when glutamine was added, indicating that the binding of the
substrate is transduced to the change in FRET efficiency (Fig. 2A).
The change in FRET efficiency was concentration dependent.
The approximate Kd of this sensor (8.5661.43610
28 M) was
consistent with the previously published affinities of glnH (1610
28
to 3610
27 M) (Table 1 and Fig. 2B) [40,41,42]. These results
indicate that glnH can be converted into a FRET sensor using the
mTFP1/venus FRET pair.
The FLIPQ-TV1.0 had very low FRET efficiency change upon
binding of glutamine (Fig. 2B, DR/R0=0.033). To further
improve the FRET efficiency change of FLIPQ-TV sensors,
linker sequences between the binding protein and fluorophores
were modified using a semi-high throughput approach. Linker
sequences at the N- and C- termini of mTFP1, and N- terminus of
venus were altered sequentially through random mutagenesis
(Fig. 3A and Fig.S2) to select for clones with an improved FRET
efficiency change. In order to avoid the potential saturation of the
sensors due to contamination by glutamine from bacterial lysate,
a version of the sensor that had ,20 times lower affinity compared
to the sensor based on wild-type glnH (FLIPQ-TV_R75K, Table 1
and Fig. 4A) was used as the starting clone for the optimization.
In each round, .700 clones were screened for an improved
FRET efficiency change (details of mutagenesis and screening
procedures are described in Fig. S2.). The sequential improvement
yielded FLIPQ-TV3.0_R75K, which had .4 fold improvement
compared to FLIPQ-TV1.0_R75K(Fig. 3B and Fig.S2, DR/
R0=0.26).
Affinity and Substrate Specificities of FLIPQ-TV3.0 Sensors
Reported physiological glutamine concentrations in the cytosol
vary significantly (22 mM oligodendrocytes and astrocytes, 4–
11 mM in glutametergic terminals, [27]. 20 mM in hepatocytes
FRET Glutamine Sensors for In Vivo Imaging
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that have a dynamic range at all physiological concentrations of
glutamine, targeted site-directed mutagenesis was performed.
Among the residues tested, R75, which forms a hydrogen bond
with the a-carboxyl group of glutamine [37], resulted in significant
changes in the affinity when mutated into K and M. Also, D157
which forms a hydrogen bond with a-amino group [37], when
mutated into N, resulted in a variant with a lower affinity (Fig.
S3A). In addition to the mutations in the binding pocket,
mutations in the residues located either at the perimeter of the
Figure 1. Configuration of a FRET glutamine sensor. (A) Open (cyan) [36] and closed (yellow, glutamine in the binding pocket is indicated in
red) [37] conformation of glnH, glutamine binding protein from E.coli. The position of the internal hairpin permissive to an insertion of FP is marked in
magenta. (B) Schematic representations of chimeric fusions between mTFP1, glnH and venus sequences.
doi:10.1371/journal.pone.0038591.g001
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a significant local conformation change upon substrate binding
(allosteric) can cause changes in affinity [41]. Among such residues
identified by de Lorimier et al., Y86 (allosteric) and W220
(peristeric) altered the affinity when mutated into A (Fig. S3B).
The resulting clones, FLIPQ-TV3.0_R75K, R75M, D157N,
R75MY86A, and R75MW220A had Kd of 1.5610
26 M,
5.3610
25 M, 1.3610
24 M, and 1.6610
23, and 7.6610
23 M,
respectively (Fig. 4A, Table 1). These sensors were named FLIPQ-
TV3.0_1.5 m,5 0m, 100 m, 2 m, and 8 m (the numbers in names
were rounded off for the simplicity). The complete list of residues
that were tested for altered affinity can be found in Table S1.
The affinity of these sensors to similar amino acids has also been
tested. FLIPQ-TV3.0_1.5 m bound to glutamate and asparagine
A
B
Figure 2. Responses of FLIPQ-TV1.0 sensor to glutamine. (A) Emission spectra of the FLIPQ-TV1.0 sensor in the absence (black squares) or in
the presence of 1 mM glutamine (open squares). A.u. : arbitrary unit. (B) Concentration-dependent change of venus/mTFP1 peak intensity ratio. The
best fit to a single binding isotherm (R=Rmax -( R max-Rmin) x [L]/([Kd]+[L]), where R is ratio, Rmax and Rmin are the maximum and minimum ratios
respectively, and [L] is ligand concentration) is indicated.
doi:10.1371/journal.pone.0038591.g002
Table 1. Affinities of FLIPQ-TV3.0 point mutants.
Mutations in glnH Kd Rapo Rsat DR/R0
WT 85 nM 1.09 1.05 0.03
R75K 1.5 mM 1.23 0.90 0.26
R75M 50 mM 1.05 0.95 0.10
D157N 130 mM 1.34 0.99 0.26
R75MY86A 1.6 mM 1.29 1.13 0.12
R75MW220A 7.6 mM 1.14 1.01 0.11
doi:10.1371/journal.pone.0038591.t001
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(Fig. 4B). The Kds to glutamate and asparagine could not be
reliably measured due to its low affinity, estimated to be .10 mM
in both cases. FLIPQ-TV3.0_50 m, 100 m, 2 m and 8 m did not
bind to glutamate, asparagine or aspartate at 10 mM concentra-
tions (Fig. 4B). From these results, we concluded that FLIPQ-
TV3.0 sensors are highly specific to glutamine.
pH Stability of FLIPQ-TV3.0 Sensors
MTFP1, in addition to its better quantum efficiency compared
to ECFP, is more stable at acidic pH (pKa 4.3) [31]. In order to
examine the pH stability of FLIPQ-TV3.0 sensors, emission
intensities in the pH range 5.25–8.0 were tested. FLIPQ-
TV3.0_1.5 m was found to be sensitive to acidic pH, with DR
declining sharply below pH 6.5. However, above pH 6.75, both
DR and emission intensities were fairly stable (Fig. 5). FLIPQ-
TV3.0_2 m and 8 m, on the other hand, maintained a reasonable
DR at more acidic pH, whereas DR declined at pH above 7.5.
FLIPQ-TV sensors were more pH-stable compared to a similar
chimeric protein that carries CFP in place of mTFP1 (Ahmad and
Okumoto, unpublished results). Since the cytosolic pH of
mammalian cells is considered to range between 7.0–7.4 [44],
we concluded that the sensor is suitable for use in the cytosol of
mammalian cells. The pH stability of these sensors makes them
more suited for detecting transport processes that accompany
cellular pH changes such as H
+-symport, as in the case of system
N-transporters, which has been proposed to mediate both the
efflux and the uptake of glutamine [45].
Live-cell Imaging of Cellular Glutamine Using FLIPQ-
TV3.0 Sensors
In order to examine whether these FLIPQ-TV3.0 sensors
function in live cells, the sensors were expressed in the cytosol of
cos7 cells, a cell line that has been used for characterizing the
activities of exogenous amino acid transporters in previous studies
[46,47]. In addition, the sensors were also expressed in SK-Hep
cells, known to express a human neutral amino acid transporter
ASCT2 which transports glutamine [48,49]. FLIPQ-TV3.0
sensors were robustly expressed in the cytosol of both of the cell
lines. FRET efficiency changes of FLIPQ-TV3.0_ 1.5 m,5 0m,
100 m, 2 m and 8 m were tested by perfusing cells expressing an
Figure 3. Improvement of the FLIPQ-TV sensor through semi-high throughput screening. (A) Schematic representation of FLIPQ-TV
3.0_R75K sensor, in which linker sequences (indicated as Ln1–3) were sequentially altered through random mutagenesis. The linker sequence of the
resulting clone (FLIPQ-TV 3.0_R75K) is indicated. (b) Emission spectra of the FLIPQ-TV3.0_R75K sensor in the absence (black squares) or in the
presence of 1 mM glutamine (open squares).
doi:10.1371/journal.pone.0038591.g003
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5 mM. In cos7 cells, responses of all of these sensors to external
glutamine applications were either undetectable or very weak and
not reproducible (Fig. S4A-C). This could be due to low uptake
capacity for glutamine relative to the activities of enzymes that
maintain the glutamine concentration in the cells. On the other
hand, a weak but reproducible response was observed in SK-Hep
cells expressing FLIPQ-TV_8 m sensor (Fig.S5).
The weak endogenous activity of glutamine uptake in cos7 cells
provides a suitable system to analyze the activity of exogenously
expressed transporters. Therefore, we expressed ASCT2, tagged
with a mCherry [50] in cos7 cells as a model of exogenous
glutamine transporter. The ASCT2-mCherry construct localized
mainly to the cytoplasm, consistent with previous reports [51,52]
(Fig. S6). When the FLIPQ-TV3.0_8 m was co-expressed with
ASCT2-mCherry, a venus/mTFP1 ratio change was observed in
Figure 4. Affinities and substrate specificities of FLIPQ-TV3.0 sensors. (A) Saturation curves of FLIPQ-TV3.0 sensors with altered affinities. (B)
Substrate specificities of FLIPQ-TV3.0_1.5 m (black), 50 m (hatched), 100 m (white), 2 m (horizontal stripes), and 8 m (gray) sensors to Gln, Glu, Asn and
Asp.
doi:10.1371/journal.pone.0038591.g004
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and 5 mM (Fig. 6A and B), indicating that glutamine taken up by
ASCT2 can be detected by the sensor expressed in the cytosol.
The decrease in venus/mTFP1 ratio through the course of
experiment is most likely due to the differential photobleaching of
the two fluorophores [53]. The ratio change was concentration-
dependent. A similar result was obtained using FLIPQ-
TV3.0_2 m sensor (Fig. S7A). In contrast, cos7 cells co-expressing
FLIPQ-TV3.0_1.5 m, which is expected to be saturated in live
cells due to its high affinity, did not respond to extracellular
glutamine (Fig. S7B).
Interestingly, FLIPQ-TV3.0_100 m also responded to the
addition of glutamine ranging from 1 mM to 625 mM, saturating
at lower concentrations (,125 mM external glutamine) compared
to the FLIPQ-TV3.0_2 m and 8 m sensors (Fig. 6C and D). This
indicates that under such conditions, the cytosolic concentration of
glutamine can fall down into the dynamic range of this sensor
(,100 mM if the concentration is down to the Kd of the sensor),
which is much lower than the range of cellular glutamine
concentrations reported so far (1–22 mM [27,54,55]). The
ASCT2 transporter is reported to be overexpressed in cancerous
cells [56], where it is assumed to have a role in meeting the
increased demand for glutamine in cancerous cells. Indeed, it has
been demonstrated that competitive inhibition of ASCT2-medi-
ated glutamine uptake by Ala, Ser and Thr inhibits the growth of
colon carcinoma [57] and hepatoma cell lines [58,59], and
accordingly, the possibility to target this transporter for pharma-
cological intervention has been suggested in the past [56,60]. Since
FLIPQ-TV3.0_100 m can report the decrease in glutamine
concentration into the sub-millimolar range, it would be possible
to utilize the sensor in combination with chemical or RNAi
libraries to identify a treatment that lowers cellular glutamine
concentrations. In addition, duplex imaging of cellular glutamine
concentration and the induction of apoptosis, using FLIPQ-TV
sensors and a sensor for apoptosis, mAmetrine-DEVD-tdTomato
[33] respectively, would offer an attractive method to correlate
cellular glutamine concentration and the induction of apoptosis
[61].
Characterization of Glutamine Transporter Properties
Using FLIPQ-TV Sensors
The cellular glutamine concentration stayed high after the
removal of extracellular glutamine, indicating that the cellular
metabolism is not sufficient to lower the level of glutamine to the
detection range of these sensors. However, the addition of small,
neutral amino acids such as Ala quickly reversed the cellular
glutamine concentration (Fig. 6 and Fig. S7A). ASCT2 is an
obligatory exchanger, and is able to mediate glutamine efflux in
the presence of other extracellular amino acids [62]. Therefore we
tested an array of amino acids for the ability to induce glutamine
efflux. Ala, Thr, Cys, Ser, and D-ser, which are recognized by
ASCT2, were able to induce glutamine efflux, whereas His, Pro,
and Lys did not promote glutamine efflux (Fig. 7). The transport of
glutamine was also dependent on extracellular sodium, consistent
with previous observations [48] (Fig. 8). Since all of these results
corroborate with the characteristics of ASCT2, we concluded that
FLIPQ-TV sensors can be utilized to monitor cytosolic concen-
trations of glutamine, and that they can be used to investigate
physiological parameters of the transporter, such as substrate
specificity and dependence on extracellular sodium. Since
genetically encoded sensors can be targeted to a single cell type
using appropriate promoters, it would be possible to utilize these
sensors to examine glutamine transport and metabolism in
a specific cell type in vivo. Such an experimental setup will be
particularly useful for tissues that consist of heterologous cell types
with distinct glutamine metabolism (i.e. glial cells and neurons).
For example, the molecular identity of the transporter that is
responsible for providing glutamine to neuronal cells is still
controversial in some cases [62,63]. Presumably genetically
encoded sensors could be utilized in combination with pharma-
cological techniques to analyze the transport system responsible
for glutamine uptake in the context of live tissue, or even in an
intact animal [64,65,66].
Figure 5. PH stability of FLIPQ-TV3.0_1.5 m (A), 2 m (B) and 8 m
(C) sensor. Venus/mTFP1 emission ratios were measured in MES-Tris
buffer with altered pH, in the absence (black squares) or in the presence
(open squares) of saturating concentrations of glutamine.
doi:10.1371/journal.pone.0038591.g005
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DNA Constructs
To construct FLIP-TV sensors, the coding sequence of E.coli
glutamine binding protein (glnH, accession NC_000913) without
the periplasmic leader sequence was amplified by PCR from
genomic DNA of E.coli K12 with BamHI and XhoI sites on the 59-
end and KpnI and HindIII sites on the 39-end respectively. Primers
used were 59- GAGGGATCCGCTCGAGGCAGGCTC-
GAAATTAGTTGTCGCGACGGA-
TACCGCCTTCGTTCCGTTTGAATTTAAACAGGGCGC-
CAAATATGTGGGCTTTGAC -39 (underlined sequence
indicates the SfoI site introduced for the insertion of mTFP1)
and 59- GAGAAGCTTGGGTACCTTTCGGTTCAGTACC-
GAACC -39. The resulting PCR product was cloned into the
BamHI/HindIII site of pRSET B vector (Invitrogen), producing
pRSET-glnH. The mTFP1 sequence with Eco47III sites on both
ends was amplified from pBAD/HisB-mTFP1 (generous gift from
Dr. Campbell) using primers 59– GAGAGCGCTGGTATGGT-
GAGCAAGGGCGAGGAGCTG –39 and 59- GAGAGCGC-
TACCGTACAGCTCGTCCATGCCGAGAGT -39. The result-
ing PCR product was digested with Eco47III and cloned into the
SfoI site of pRSET-glnH. The venus sequence with KpnI at the 59-
end and HindIII at the 39- was digested from pRSET-FLIPEWT
[40] and fused in-frame to the 39- end of the glnH sequence. The
resulting construct was named pRSET-FLIPQTV. Point mutants
were created by site-directed mutagenesis [67]. For the optimiza-
tion of linker sequences between the fluorophores and binding
protein, the following primers were used: 59-
GCCCTTGCTCACCATNNNNNNCTGTTTAAATTCAAAC
-39 (Fig. 3A, Ln1), 59- GTCAAAGCCCACA-
TATTTGGCGCTNNNCTTGTACAGCTCGTC -39 (Fig. 3A,
Ln2), and 59- CCCGGTGAA-
CAGCTCNNNNNNTTTCGGTTCAGTACC -39 (Fig. 3A,
Ln3).
A plasmid containing human ASCT2 (ATCC MGC 1387) was
purchased from the American Type Culture Collection (ATCC).
The ASCT2-monomeric Cherry (mCherry) fusion was made by PCR-
stitching. The ASCT2 sequence without the stop codon, followed
by a linker sequence was amplified using a forward primer ASCT2-
F:5 9-GAGAAGATCTCGGTGCTTCCCATCATGGTGGCC-
GATCCTCCTCGAG -39 and reverse primer ASCT2-R:5 9-
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Figure 6. In vivo glutamine measurements using FLIPQ-TV3.0_8 m and 100 m sensors. (A) The venus/mTFP1 ratio of cos7 cells co-
expressing FLIPQ-TV3.0_8 m sensor and ASCT2-mCherry. The cells were perfused with HEPES-buffered Hank’s buffer. Timepoints when extracellular
glutamine (red) and 5 mM Ala (blue) was added to the perfusion media are indicated as boxes above the graph. Solid and dashed lines represent two
individual cells measured in the same experiment. (B) The intensities of mTFP1 and venus channels in the experiment shown in (A). The values were
corrected for photobleaching and normalized to the baseline. (C) and (D) A similar experiment as in (A) and (B), performed with cos7 cells expressing
the FLIPQ-TV3.0_100 m sensor.
doi:10.1371/journal.pone.0038591.g006
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GATTCCTTCTCAGAGGC -39. The mCherry sequence was
amplified using a forward primer mCherry-F:5 9-
GGGGGCGGTGGAGGAGATCCCGCCACCATGGTGAG-
CAAGGGCGAGGAGGAT -39 and a reverse primer mCherry-R:
59- GAGAGAATTCCTTACTTGTACAGCTCGTC-
CATGCCGCC -39. The underlined sequences represent a com-
plementary region between two fragments. The two PCR
fragments were extended in the second PCR cycle with ASCT2-
F and mCherry-R primers. The resulting ASCT2-mCherry fusion
fragment was digested with BglII and EcoRI, then cloned in
between BamHI and EcoRI sites in pENTR1A vector (Invitrogen).
The ASCT2-mCherry sequence was recombined into pcDNA3.2
V5-DEST vector (Invitrogen) using LR-clonase II, following the
manufacturer’s instruction.
A
B
Ala Ser Cys Thr D-ser Ala
Pro Lys His
Figure 7. Elimination of cellular glutamine through the ASCT2 transporter in the presence of external amino acids, visualized using
FLIPQ-TV3.0_8 m sensor. (A) Cytosolic glutamine is exported by the addition of extracellular Ala, Ser, Cys, Thr, and D-ser. Timepoints when
extracellular glutamine (red boxes) or other amino acids (blue boxes) were added to the perfusion media are indicated as boxes above the graph. (B)
Addition of Pro, Lys, His (filled boxes) does not alter cytosolic glutamine concentration, whereas the addition of Ala (blue boxes) promotes the export
of glutamine. Solid and dashed lines represent two individual cells measured in the same experiment. All amino acids were added at 5 mM external
concentrations.
doi:10.1371/journal.pone.0038591.g007
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Cos7 (ATCC CRL-1561) and SK-Hep (ATCC HTB-52) cells
were purchased from ATCC. Cells were cultured in Dulbeccos
Modified Eagles Medium supplemented with 5% cosmic calf
serum, 100 U/ml penicillin, and 100 U/ml streptomycin. Cells
were cultured at 37uC under an atmosphere of 5% CO2. For
imaging, cells were plated on an 8-well chamber with glass bottom,
coated with poly-L-lysine. Transfection was performed using
Lipofectamine 2000 (Invitrogen). For transfecting cells, 400 ng of
FLIPQ-TV constructs and 1.2 mgo fASCT2-mCherry construct/well
(100 mm
2) were used.
High-throughput Protein Purification
BL21 (DE3) gold (Stratagene) colonies expressing randomly
mutagenized FLIPQ-TV sensors were cultured in 2 ml of SB
medium in 96 well plates. Cells were lysed with a sonicator
equipped with a 96-pin tip, and purified using 96 well Ni-NTA
columns (Qiagen). Emission spectra for each sample in the
A
B
Figure 8. Responses of cos7 cells co-expressing the FLIPQ-TV3.0_8 m sensor and ASCT2-mCherry to external glutamine in the
absence (A) or in the presence of 13.4 mM (,10% of normal Hank’s buffer) of extracellular sodium. Timepoints when 5 mM
extracellular glutamine (red box) or 5 mM Ala (blue box) are indicated as boxes above the graph. Solid and dashed lines represent two individual cells
measured in the same experiment.
doi:10.1371/journal.pone.0038591.g008
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at 450 nm using a plate reader (Synergy4, BioTek), and clones
with larger changes in mTFP1 and venus peaks (494 and 535 nm
respectively) were kept for further analysis.
In vitro Characterization of FLIPQ Sensors
Bacterial expression constructs for FLIPQ sensors were in-
troduced into E.coli BL21(DE3) Gold (Stratagene), and the
expressed sensor proteins were purified using Ni-NTA columns
as described in [68]. Ligand titration curves were obtained by
using a microplate reader (Synergy 4, BioTek), with excitation at
450 nm and emission at 490 nm and 535 nm for mTFP1 and
venus, respectively. To determine the Kd of each FLIPQTV
sensor, sensor protein was mixed with different concentrations of
glutamine in 20 mM HEPES buffer, pH 7.0, and venus/mTFP1
ratio was measured. The Kd was determined by fitting the
saturation curve to a single site binding isoterm: S=(r-rapo)/(rsat –
rapo)=[L]/([Kd]+[L]), where S is saturation, [L] is ligand concen-
tration, r is ratio, rapo is the ratio without ligand, rsat is the ratio at
saturation. Saturation curves were obtained from at least three
independent protein preparations.
In vivo Imaging of Cell Cultures
Cells were imaged 36–72 hrs post-transfection using an
epifluorescence microscope (IX81, Olympus) with appropriate
filters (mTFP1 excitation: 455/10, mTFP1 emission: 495/30,
venus excitation: 470/24, venus emission: 535/30, mCherry
excitation: 560/40, mCherry emission: 630/75). The cells were
perfused with Hank’s balanced saline solution (HBSS), supple-
mented with 25 mM HEPES and 4.2 mM sodium bicarbonate,
pH 7.35. Prior to the time-course experiments, the cells were
perfused with 5 mM Ala for 2 min to lower the concentration of
intracellular glutamine, then washed briefly with HBSS. The
images were collected and analyzed using appropriate software
(Slidebook, 3I). For testing transporter activities in Na
+ - free
buffer, sodium components in HBSS were replaced with choline,
and the cells were incubated for 15 min in this choline-based
buffer prior to perfusion with amino acids.
Supporting Information
Figure S1 The surface views of glnH in open- and closed- forms.
(A) Alignment between the open- (blue, 1GGG) and closed- (beige,
1WDN) structures, shown in ribbon diagrams. Glutamine
molecule in the cleft is represented as ball-and-stick. C-termini,
where the venus protein is fused in FLIPQ-TV1.0 is marked in
magenta. (B) and (C) The surface views of the open- (B) and closed
(C) structures, superimposed on the ribbon diagram shown in (A).
Note the large change in spatial constraint in the vicinity of C-
termini (represented in magenta).
(TIF)
Figure S2 Optimization of FLIPQ-TV sensors. The linkers
(Ln1–3) were iteratively mutagenized, and clones representing
individual mutagenesis events were screened for an improved DR/
R0. The number of clones screened on each step, and DR/R0 of
each generation of sensors are indicated.
(EPS)
Figure S3 Residues that were altered to produce affinity
mutants. (A) Ball-and-stick representation of the glutamine
molecule in the cleft and residues in the cleft likely to form
hydrogen bonds with the glutamine. (B) The location of Tyr86 and
Trp220 that are mutated in FLIPQ-TV3.0_2 m and 8 m.
(EPS)
Figure S4 Cos7 cells expressing FLIPQ-TV3.0_100 m (A), 2 m
(B), 8 m (c) sensors perfused with extracellular glutamine. The cells
were perfused with HEPES-buffered Hank’s buffer. Timepoints
when extracellular glutamine (red) and 5 mM Ala (blue) were
added to the perfusion media are indicated as boxes above the
graph. Solid and dashed lines represent two individual cells
measured in the same experiment.
(EPS)
Figure S5 A SK-Hep cell expressing FLIPQ-TV3.0_8 m sensor
perfused with extracellular glutamine. Timepoints when 5 mM
glutamine (red) or 5 mM Ala (blue) were added to the perfusion
media are indicated as boxes above the graph.
(EPS)
Figure S6 Cos7 cells co-expressing ASCT2-mCherry fusion
(red) and FLIPQ-TV3.0_8 m (green). ASCT2 signal is mostly
found on the endomembrane, whereas FLIPQ-TV3.0_8 m is
distributed throughout the cytosol.
(EPS)
Figure S7 In vivo glutamine measurement using FLIPQ-
TV3.0_2 m sensor. (A) Venus/mTFP1 ratio of cos7 cells co-
expressing FLIPQ-TV3.0_2 m sensor and hASCT2-mCherry.
The cells were perfused with HEPES-buffered Hank’s buffer.
Timepoints when extracellular glutamine or alanine (5 mM) were
added to the perfusion media are indicated as red and blue boxes
above the graph. Solid and dashed lines represent two individual
cells measured in the same experiment. (B) The intensities of
mTFP1 and venus channels in the experiment shown in (A). (C)
and (D) Venus/mTFP1 ratio and intensities of mTFP1 and venus
channels of cos7 cells co-expressing FLIPQ-TV3.0_1.5 m sensor
and hASCT2-mCherry. Timepoints when extracellular glutamine
and alanine (5 mM) were added are indicated as in (A).
(TIF)
Table S1 A complete list of mutations in glnH that were tested
for altered affinity.
(DOCX)
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